TY  - JOUR
AU  - Villanueva, Vicente
AU  - Carreno, Mar
AU  - Gil-Nagel, Antonio
AU  - Serrano-Castro, Pedro Jesus
AU  - Serratosa, Jose Maria
AU  - Toledo, Manuel
AU  - Alvarez-Baron, Elena
AU  - Gil, Alicia
AU  - Subias-Labazuy, Silvia
PY  - 2021
DO  - 10.1016/j.yebeh.2021.108222
SN  - 1525-5050
UR  - https://hdl.handle.net/10668/24378
T2  - Epilepsy & behavior
AB  - Introduction: Epilepsy is a serious neurological disease, ranking high in the top causes of disability. Approximately 40% of patients with epilepsy are pharmacoresistant after their seizures failed at least two antiseizure medications (ASMs). Adult...
LA  - en
PB  - Academic press inc elsevier science
KW  - Drug-resistant epilepsy
KW  - Focal-onset seizures
KW  - Antiseizure medications
KW  - Multi-criteria decision analysis
KW  - Epilepsy
KW  - Spain
KW  - Quality-of-life
KW  - Health
KW  - Definition
KW  - Diagnosis
KW  - Framework
KW  - Impact
KW  - Cost
KW  - Hta
TI  - Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA)
TY  - research article
VL  - 122
ER  -